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Background: Fibromyalgia (FM) is a condition characterized by widespread pain and is estimated to affect 0.5-5%
of the general population. Historically, it has been classified as a rheumatologic disorder, but patients consult
physicians from a variety of specialties in seeking diagnosis and ultimately treatment. Patients report considerable
delay in receiving a diagnosis after initial presentation, suggesting diagnosis and management of FM might be a
challenge to physicians.
Methods: A questionnaire survey of 1622 physicians in six European countries, Mexico and South Korea was
conducted. Specialties surveyed included primary care physicians (PCPs; n=809) and equal numbers of
rheumatologists, neurologists, psychiatrists and pain specialists.
Results: The sample included experienced doctors, with an expected clinical caseload for their specialty. Most
(>80%) had seen a patient with FM in the last 2 years. Overall, 53% of physicians reported difficulty with diagnosing
FM, 54% reported their training in FM was inadequate, and 32% considered themselves not knowledgeable about
FM. Awareness of American College of Rheumatology classification criteria ranged from 32% for psychiatrists to 83%
for rheumatologists. Sixty-four percent agreed patients found it difficult to communicate FM symptoms, and 79%
said they needed to spend more time to identify FM. Thirty-eight percent were not confident in recognizing the
symptoms of FM, and 48% were not confident in differentiating FM from conditions with similar symptoms.
Thirty-seven percent were not confident developing an FM treatment plan, and 37% were not confident managing
FM patients long-term. In general, rheumatologists reported least difficulties/greatest confidence, and PCPs and
psychiatrists reported greatest difficulties/least confidence.
Conclusions: Diagnosis and managing FM is challenging for physicians, especially PCPs and psychiatrists, but other
specialties, including rheumatologists, also express difficulties. Improved training in FM and initiatives to improve
patient-doctor communication are needed and may help the management of this condition.Background
Fibromyalgia (FM) is a disorder characterized by wide-
spread pain [1]. The American College of Rheumatology
(ACR) criteria classify patients as having FM if they have
widespread pain (all four quadrants involved) for at least
3 months and at least 11 out of 18 tender points on
digital palpation with a force of 4kg [2]. Although not
essential for diagnosis, sleep disturbance, fatigue and
morning stiffness are present in the vast majority of
patients, and other quite common symptoms include* Correspondence: Danielle.Petersel@pfizer.com
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reproduction in any medium, provided the orcognitive problems, paresthesias, headache, irritable
bowel or bladder and anxiety [2,3]. In fact, the ACR has
recently published modified preliminary diagnostic cri-
teria, following the 1990 classification criteria, which en-
able diagnosis without the tender point examination,
and includes the severity of fatigue, waking unrefreshed
and cognitive symptoms as core diagnostic assessments
[4]. Fibromyalgia is estimated to have a worldwide
prevalence in the order of 0.5-5% in the general popula-
tion [5-8], and when classified using the ACR 1990 cri-
teria is approximately seven times more prevalent in
women than in men [5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of the rheumatology specialty being a condition of mus-
cular pain that for centuries was known as rheumatism,
muscular rheumatism or non-articular rheumatism. The
ACR issued classification criteria in 1990, and medical
training in FM is generally encompassed within rheuma-
tology training at an undergraduate level. Despite FM
being a rheumatologic condition, patients very often
consult with physicians from variety of specialties other
than rheumatology [9]. In a survey of 800 FM patients
in six European countries, Mexico and South Korea,
patients most commonly presented to primary care phy-
sicians (PCPs), but also to neurologists and psychiatrists
[9]. These same patients reported FM having trouble
symptoms and a meaningful impact on their lives. In
addition, it took an average of 2.3 years after experien-
cing symptoms and presentation to an average of 3.7
physicians before a diagnosis of FM was made [9]. This
suggests that the diagnosis and management of FM
might be a challenge to physicians. Indeed, while recom-
mendations for FM diagnosis (the use of ACR criteria
and the Fibromyalgia Impact Questionnaire) and treat-
ment (aerobic exercise, cognitive behavioural therapy,
amitriptyline, duloxetine, milnacipran, pregabalin) exist,
these recommendations have yet to be adopted into a
standard diagnostic or treatment algorithm [10]. This
may be reflected in the significant differences that have
been reported, in terms of FM diagnostic and treatment
patterns, by physicians of different specialties in the Uni-
ted States [11].
Studies conducted in Canada have shown, through
self-report, that physicians have differing attitudes to-
wards the etiology, diagnosis, and treatment of FM
[12,13]. Further, some physicians report difficulty in
diagnosing/managing FM and feel they lack the know-
ledge and skill to manage FM patients [13]. Here, we re-
port the findings of a large-scale international survey of
physicians and their perceptions of FM. The underlying
framework of this survey was that a general lack of phys-
ician awareness, recognition, and understanding of FM
contributes to deficits in the diagnosis and management
of FM patients. The goal of our survey was to assess the
knowledge and understanding of FM among physicians
of different specialties, in hopes of identifying specific
elements which contribute to the difficulty in diagnosing
and managing FM. Steps could then be taken to improve
knowledge and understanding of these specific elements
in hopes of improving patient care.
Methods
Approach
A survey was designed by Pfizer Inc in conjunction with
Harris InteractiveW to yield data on awareness, know-
ledge and perceptions regarding the diagnosis andtreatment of FM among physicians of different special-
ties. Ethical approval for this study was not required as
per the countries regulations.
Sampling and recruitment
This survey was conducted in six European countries
(France, Germany, Italy, The Netherlands, Spain, United
Kingdom), Mexico and South Korea. To ensure data sta-
bility and enable robust analysis of PCPs versus specialist
at a country level, it was planned to survey 100 PCPs
and 100 specialists in each country. With a maximum
potential sampling variance of 9.8 percentage points at
the 95% confidence level, a sample size of 100 is gener-
ally accepted as providing reasonable data stability and
statistical reliability. The sample of 100 specialists per
country consists of roughly 25 interviews with each of
the four specialties; rheumatologists, neurologists, psy-
chiatrists and pain specialists. This specialist sample
was designed to be analyzed at the aggregate level of
“specialist” in each country, not by individual specialty.
Physicians were randomly sampled from proprietary
databases, association lists, phone directories and other
commercially available sample sources. Physicians were
invited by phone or face-to-face to participate in the sur-
vey, explained the purpose of the survey and why they
were chosen, and assured their responses would be kept
confidential. To qualify for participation in the study,
physicians must have had a primary specialty in general/
family practice, internal medicine, rheumatology, neur-
ology, psychiatry, anesthesiology (Mexico), pain manage-
ment and/or sub-specialty in pain management or pain
treatment; be in active patient practice and reside in one
of the countries included in the study. Physicians who
had not seen a FM within the last two years were
included in the study, since the objective was to obtain a
representative sample of country physicians and assess
their general knowledge, understanding, and experience
with fibromyalgia regardless of whether or not they are
actively treating fibromyalgia patients. Physicians who
completed the survey received a cash honorarium
equivalent to 30-100$ US dollars, depending on phys-
ician specialty and country. In addition, multiple follow-
up calls were made to encourage participation.
Data collection
The survey (Additional file 1)was a 15-min interview
conducted via telephone, using computer-assisted tele-
phone interviewing (CATI) technology in all countries
except South Korea, where interviews were face-to-face
in compliance with cultural norms. The interviews were
conducted by trained interviewers using a fully struc-
tured questionnaire. The CATI system allows the pro-
grammed survey to be displayed on a computer screen
so the interviewer can read each question, enter a
Perrot et al. BMC Health Services Research 2012, 12:356 Page 3 of 8
http://www.biomedcentral.com/1472-6963/12/356response and then move on to the next screen. Skip pat-
terns, depending on the answer to the previous question,
are programmed into the survey and not reliant on the
interviewer. The survey was conducted between February
and April 2008. At the time there were no medications
approved for FM in any of the countries surveyed. The
questionnaire included questions about physicians’ med-
ical practice, their behaviors and perceptions related to
diagnosis and treatment of FM. Questions were generally
answered as yes/no or on 5-point Likert scales, e.g., 1 =
strongly agree, 2 = somewhat agree, 3 = neither agree
nor disagree, 4 = somewhat disagree, 5 = strongly dis-
agree. Questions included lists of possible answers that
were generally read and selected by the physicians. Not
all physicians received the same identical set of ques-
tions, as some were contingent on whether the physician
had seen patients with FM in the last 2 years. Specific
details of questions and responses are provided in the
results below.Data analysis
Data from all countries were pooled for presentation in
this publication. Statistical significance at the 95% confi-
dence level was tested using Student’s t test on propor-
tions and means. The survey was developed by Harris
Interactive in close cooperation/partnership with PfizerTable 1 Characteristics of the physician sample
PCP
(n=809)a
Years in practice, mean n 20.1c
Total patients per month estimate, mean n 614.6b, c, d, e
Seen FM patient in the last 2 years, yes % 79d
FM patients in the last 2 years*, mean n 31.5
FM patients in the past 2 years who are women*, mean % 83.6





Very little, % 45%b, c, d, e
None at all, % 17b
Knowledge about FM§
Mean score 2.7d
Very knowledgeable, % 8
Knowledgeable, % 55d
Not very knowledgeable, % 34b, c, e
Not at all knowledgeable, % 2
*Among those physicians who have seen patients with FM in the last 2 years.
†Somewhat or very difficult to diagnose.
‡Self-rating of training in FM: 1 = none at all; 2 = very little; 3 = adequate; 4 = exce
§Self-rating of knowledge of FM: 1 = not at all knowledgeable; 2 = not very knowle




In total, 1622 physicians were interviewed. In each coun-
try the target number of physicians in each specialty was
recruited and interviewed, and in some countries slightly
more were interviewed (up to 103 PCPs and up to 27 in
a specific specialty). Characteristics of the sample
according to specialty are shown in Table 1.
Physician practice characteristics
Overall, the average duration of clinical practice was ap-
proximately 20 years, and across specialties the means
were generally similar, although the difference between
neurologists and each of the PCPs and psychiatrists was
statistically significant. Primary care physicians saw the
greatest number of patients per month (mean, 615), sig-
nificantly exceeding all other specialties. Among the
other specialties rheumatologists and neurologists saw
on average >300 patients/month, while psychiatrists and
pain specialists saw >200/month. Almost all of the rheu-
matologists had seen a patient with FM in the last 2
years, and the frequency was significantly greater than








18.9 17.8 20.8c 19.5
355.4d, e 322.3d 215.2 267.1d
93a, c, d, e 79d 63 87a, c, d
126.9a, c, d 53.1a, d 26.0 86.8a, d
87.7a, c, d, e 84.1 83.9 82.3
31 50b 53b 50b
2.7a, c, d, e 2.5a, d 2.1 2.5a, d
16a, c, d 9a, d 3 10a, d
52%a, d 45%a, d 32% 46%a, d
23 33b 37b 29
9 13 27a, b, c, e 14
3.2a, c, d, e 2.8a, d 2.6 2.9a, d
33a, c, d, e 15a 9 17a, d
54d 54 45 59d
12 25b 39b, c, e 20b
1 5a, b 7a, b, e 2
llent.
dgeable; 3 = knowledgeable; 4 = very knowledgeable
ps (i.e., physician specialties) being analyzed.
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of training in FM among group differences were noted,
with PCPs and psychiatrists indicating poorer levels of
training than the other specialties, and rheumatologists
generally reporting significantly better training than
others. Self-reported knowledge of FM was likewise vari-
able across specialties, with rheumatologists having the
highest ratings and PCPs and psychiatrists having the
lowest.Physician attitudes towards diagnosing fibromyalgia
A notable percentage of physicians (53%) responded that
they found FM somewhat or very difficult to diagnose
(Table 1). The percentages of physicians by specialty
who agree with the reasons proposed as contributing to
difficulty in diagnosis are shown in Figure 1. Overall,
more than half (64%) the physicians across specialties
considered that it was difficult for patients to communi-
cate their FM symptoms. Most (85%) physicians found
FM symptoms difficult to discriminate from other condi-
tions, and 75% were not always comfortable with diag-
nosing FM. Compared with all other specialties, PCPs
were significantly more likely than others to find it diffi-
cult to discriminate FM symptoms from other condi-
tions; pain specialists were significantly more likely to
feel physicians needed to spend more time to identify
FM. Among those physicians who have seen FM patients
in the past 2 years, the overall patterns of responses to
the questions on diagnosis were similar for the entire
sample, although differences across specialties were not
as great (data not shown).0%
Physicians need














Figure 1 Physicians agreeing* with the reasons proposed as contribu
agreed. a, b, c, d, and e, indicate statistically significant difference (P<0.05) amThe percentages of physicians who reported confi-
dence in recognizing the symptoms of FM and in differ-
entiating FM from conditions with similar symptoms
was variable across specialities (Figure 2). Significantly
more rheumatologists were more confident than the
other specialities in both recognition of symptoms and
differentiation from other conditions.
In total, 48% of all respondents were aware of the
ACR Fibromyalgia Classification Criteria [2]. These cri-
teria classify a patient as having FM if they have wide-
spread pain (all four quadrants involved) for at least 3
months and at least 11 out of 18 tender points on digital
palpation with a force of 4kg. Awareness of the ACR cri-
teria was highest among rheumatologists (83%), which
was significantly greater than all of the other specialties.
Awareness among other specialties was as follows: pain
specialists (56%), neurologists (55%), PCPs (40%) and
psychiatrists (32%). Of the 725 physicians who were
aware of ACR criteria and had treated an FM patient in
the last 2 years, 71% said they use the ACR criteria to
identify FM in their clinical practice. Use of ACR criteria
was highest among rheumatologists (83%), followed by
pain specialists (77%), PCPs (69%), neurologists (65%)
and psychiatrists (41%).Physician attitudes towards treating fibromyalgia
Physicians who had seen FM patients in the past 2 years
identified symptoms from a list of 14 that they felt were
not adequately treated by currently available treatment
options (Table 2). Generally, the pattern of responses



























ting to difficulty in diagnosis. *Those who strongly or somewhat









































Figure 2 Physicians who reported being confident* in aspects of FM diagnosis and management. *Those who were very confident or
confident. a, b, c, d, and e indicate statistically significant difference (P<0.05) among the subgroups (i.e., physician specialties) being analyzed.
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monly selected in each group.
Significantly more rheumatologists than the other four
specialties were confident in developing a treatment plan
for FM (Figure 2), with approximately half the PCPs and
psychiatrists expressing confidence in doing so. Differ-
ences among specialties in the percentages expressing
confidence in managing FM patients long-term were not
as great, mainly because fewer rheumatologists expressed
confidence in managing FM patients long-term.
Discussion
This survey collected data using structured question-
naires from 1622 physicians across five specialties fromTable 2 Percentage of physicians who believe that available t






Chronic widespread pain 50 60a
Difficulty concentrating 44 47
Numbness/tingling 40 38
Feelings of depression 37 38
Stiffness 35 33
Problems sleeping 31 28
Feelings of anxiety 31 34
Headaches 28 30
*At the time the survey was conducted no medications for FM were licensed in any
a, b, c, d, and e indicate statistically significant difference (P<0.05) among the subgroeight countries. Based on the average time in practice
(~20 years), the sample can be considered to be experi-
enced in the practice of medicine. Expectedly, PCPs saw
far more patients/month than the other specialties, with
frequency of patient consultations that approximates to
25 to 30 patients per working day. Psychiatrists and pain
specialists saw fewer than half this number of patients,
with rheumatologists and neurologists seeing just over
half. This is consistent with what are accepted “norms”
in medical practices, whereby PCPs see many more
patients than other specialties in a typical working day.
As FM is classified as a rheumatologic condition
(ACR) [2,4] and it is internationally recognized as a
















of the countries surveyed.
ups (i.e., physician specialties) being analyzed.
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gists (93%) surveyed reported seeing a patient with FM
in the past 2 years as did most pain specialists (87%). Al-
though the reported frequencies were lower among the
other specialties, over two-thirds of these physicians
reported seeing a patient with FM at some time in the
last 2 years. Given that the prevalence of FM is esti-
mated at 0.5-5% of the general population [5-8], that
patients with FM are known to be frequent presenters to
medical practitioners and high utilizers of health care
resources [14] and that patients report difficulty in re-
ceiving a diagnosis and see multiple physicians [9], it is
not surprising that the majority of neurologists and psy-
chiatrists had also seen patients with FM in the past 2
years.
The finding that 21% of PCPs reported they had not
seen a patient with FM in the past 2 years was a little
surprising, as a PCP might be expected to have 1500–
3000 patients in the community in their care [15] and
that it has been estimated that FM constitutes 5% of a
PCP’s consultation rate [16,17]. On this basis one would
expect almost all PCPs to see a patient with FM in a 2-
year period. The difficulties in making a diagnosis
reflected by the PCP responses may explain why almost
one in five of the PCPs claimed not to have seen a pa-
tient with FM in the last 2 years. Among those physi-
cians who reported seeing a patient with FM in the last
2 years, the number of patients they saw, as expected,
was quite variable across specialties, with rheumatolo-
gists seeing the highest number (average, 127), followed
by pain specialists (average, 87), with psychiatrists seeing
the fewest patients (average, 26 in 2 years).
Over half (53%) of the physicians said that they had
difficulty diagnosing FM. Primary care physicians were
significantly more likely than all other specialists to re-
port that it is somewhat or very difficult to diagnose FM;
rheumatologists were the least likely to report this. This
is not surprising, given that a notable proportion (54%
overall) said they received inadequate training in FM,
and many (32% overall) still considered themselves not
to be very knowledgeable about FM despite their experi-
ence in medical practice. Expectedly, the rheumatolo-
gists had the highest ratings on their level of training
and knowledge. The finding that <60% of specialists
(other than rheumatologists) were aware of the ACR cri-
teria for FM classification that describes the tender point
examination is consistent with the expressed inadequacy
in training. It is worth noting that the modified prelim-
inary diagnostic ACR criteria published in 2010, does
not include a mandatory tender point examination to
reach a diagnosis [4]. This may make the condition eas-
ier for clinicians to diagnose in the future if they receive
training in using the revised criteria. The PCPs and psy-
chiatrists reported the lowest ratings for training andknowledge, which probably reflects the fact that there
are many more prevalent conditions that these special-
ties have to manage and have higher priority in their
training. Nonetheless, the self-reported inadequacy of
training and paucity of knowledge reported by many
PCPs, in particular, is concerning. In many health care
systems, including some of those surveyed, PCPs are the
gatekeepers who provide referrals to other specialties
and are very often the ongoing providers of care for
patients with FM. Thus, PCPs having adequate training
and good knowledge of FM is desirable.
In addition to training and knowledge of FM, the phy-
sicians were asked to rate factors that contributed to
making FM diagnosis difficult. Over half (64%) the physi-
cians overall agreed that it was difficult for patients to
communicate their symptoms. This concurs with find-
ings from the companion survey in which 59% of patients
with FM said they found it difficult to communicate their
FM to physicians [9]. The communication difficulties be-
tween patients and their doctors may, in part, be due to
the nature of the disorder itself, as its presentation is
variable across patients with a variety of symptoms, in
addition to characteristic and otherwise unexplained
chronic widespread pain, fatigue and sleep disturbance
being manifest [18]. The fact that >75% of each of the
specialties agreed that the need to spend more time to
identify FM contributed to difficulty with diagnosis is
consistent with the companion survey in which 74% of
patients said that physicians need to spend more time to
diagnose FM, which may be a factor that impacts the
communication between patients and physicians.
Discomfort with making a FM diagnosis and difficulty
discriminating FM symptoms from other conditions
contributed to diagnostic difficulties according to most
physicians. Notably, almost all PCPs (90%) reported that
difficulty in discriminating FM symptoms from other
conditions contributed to diagnostic difficulties, and the
frequency was significantly greater than the other spe-
cialties. Consistent with this, only 44% of PCPs and only
34% of psychiatrists reported being confident in differen-
tiating FM from conditions with similar symptoms. By
contrast most rheumatologists were confident in recog-
nizing FM symptoms (87%) and discriminating these
from conditions with similar symptoms (77%), an
expected finding, given the level of training and expos-
ure to FM patients they will have likely received. The
percentages of neurologists and pain specialists who
reported being confident in recognition and discrimin-
ation of FM symptoms fell between the levels reported
by the rheumatologists and the PCPs/psychiatrists, prob-
ably reflecting greater level of expertise in managing
chronic painful conditions. Overall, these findings high-
light the need for improved physician training in the
diagnosis of FM, particularly PCPs and psychiatrists.
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plan and in the management FM patients long-term
were the psychiatrists, with fewer than half the respon-
dents expressing confidence in either aspect of manage-
ment. The levels of confidence were a little higher
among the PCPs, but a significant minority did not ex-
press confidence. While most rheumatologists (80%)
were confident in developing a treatment plan, only
two-thirds were confident they could manage FM
patients long-term. The fact that approximately half of
each of the specialty groups surveyed believed that
current treatments did not adequately treat cardinal
symptoms of FM, such as chronic widespread pain and
fatigue, offers some explanation that a notable propor-
tion of physicians did not express confidence in man-
aging FM long-term.
Overall, our findings are similar to those reported by
Hayes et. al. [13], who examined the attitudes and
experiences of Canadian physicians with respect to FM.
In that study, a notable proportion of general practi-
tioners (36%) and specialists (25%) doubted their ability
to diagnose FM. Deficiencies in the treatment of FM
were also reported, particularly in the knowledge of
current treatment options and in the knowledge of
symptom monitoring tools. As with our findings, general
practitioners reported deficiencies in diagnosing and
treating FM more frequently than specialists.
An important limitation of all opinion research, and
this study is not an exception, is that respondents (physi-
cians in this case) may not perfectly recall and assess
their experiences. Respondents’ attitudes and percep-
tions are subject to some potential changes in the course
of time. The survey provides a snapshot of the respon-
dents’ experiences and does not seek to address how
these might have changed longitudinally. It must also be
noted that the questionnaire is limited in that answers
are framed in the “yes/no” or 5-point Likert scale for-
mats, which cannot capture detailed accounts of phys-
ician experience or additional, unanticipated responses.
Finally, these surveys were conducted across multiple
countries having different healthcare systems and with
physicians coming from different cultural backgrounds.
Therefore, care must be taken in attempting to
generalize our findings to physicians from countries not
included in the current study.
A key finding of our research is that many physicians
in the countries surveyed, particularly PCPs, report an
overall lack of knowledge and skill in the diagnosis and
treatment of FM. Recently, steps have been taken to sim-
plify the diagnosis and care of patients with FM that
should be brought to the attention of such physicians.
New ACR guidelines, for example, disregard the tender-
point examination that was often problematic for physi-
cians lacking a background in rheumatology and employa severity scale for monitoring common FM symptoms
[19]. Newly developed tools, such as the Fibromyalgia
Rapid Screening Tool (FiRST) and the VASFIQ Brief
Symptom Scale, also simplify symptom assessment. Un-
like the FIQ, which can be limited by its length and scor-
ing complexity, the FiRST and the VASFIQ are designed
to quickly assess patients and initiate treatment in busy
clinics [20,21]. Diagnostic criteria and symptom assess-
ment tools will likely continue to be revised and devel-
oped as our understanding of the etiology and care of
FM deepens. As such, physicians should try to remain
update with the latest guidelines and literature. This
should enhance their comfort level with FM and result
in improved patient care.
Conclusions
Fibromyalgia is a challenging disorder to diagnose and
manage. Many physicians from a variety of specialties
reported difficulties in diagnosing FM, and many were
not confident in differentiating the symptoms of FM
from other conditions. Physicians and patients com-
monly report that patients have difficulty communicat-
ing symptoms, which may contribute to the diagnostic
challenges. The majority of physicians and patients
agreed that physicians need to spend more time to iden-
tify FM. Over half the physicians surveyed believed that
treatments available at the time were inadequate for core
symptoms, such as pain and fatigue. Many physicians
were not confident in the development of a treatment
plan and in the management of FM patients long-term.
Many physicians believed their training in FM was inad-
equate and that they are not knowledgeable about the
condition. In general, rheumatologists reported least dif-
ficulties/greatest confidence, and PCPs and psychiatrists
reported the greatest difficulties/least confidence. Given
that meaningful numbers of FM patients are in the care
of PCPs and are often also seen by specialists other than
rheumatologists, improved training in FM and initiatives
to improve patient-doctor communication may help the
management of this condition.
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